Alloway v. Hodge

72 F. App'x 812
CourtCourt of Appeals for the Tenth Circuit
DecidedAugust 13, 2003
Docket02-7104
StatusUnpublished
Cited by5 cases

This text of 72 F. App'x 812 (Alloway v. Hodge) is published on Counsel Stack Legal Research, covering Court of Appeals for the Tenth Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Alloway v. Hodge, 72 F. App'x 812 (10th Cir. 2003).

Opinion

*813 ORDER AND JUDGMENT *

BRORBY, Senior Circuit Judge.

After examining the briefs and appellate record, this panel has determined unanimously to grant the parties’ request for a decision on the briefs without oral argument. See Fed. R.App. P. 34(f); 10th Cir. R. 34.1(G). The case is therefore ordered submitted without oral argument.

Defendants in this case appeal from the district court’s order denying their motion to terminate an injunction entered under the Prison Litigation Reform Act (PLRA). The injunction requires defendants to continue to administer plaintiff Arthur Alloway’s prescribed medical treatment until final resolution of Alloway’s action filed pursuant to 42 U.S.C. § 1983. Our jurisdiction arises under 28 U.S.C. § 1292(a)(1), and we affirm.

I.

Alloway, an Oklahoma state prisoner, filed his § 1983 complaint seeking relief for the alleged denial of prescribed medical treatment for his diagnosed liver disease. The facts leading up to the district court’s issuance of injunctive relief are well known to the parties and recounted in detail in the court’s September 21, 2001 order. In that order, the district court denied Alloway’s request for examinations by two particular private physicians, as well as his request for a resumption of Actigall, a medication used to dissolve certain types of gallstones. Nevertheless, the court granted Alloway’s request for resumption of his prescribed treatment of Oxycontin (a narcotic), milk thistle, and vitamin C, finding that Alloway had shown a substantial likelihood of success on his claim that defendants acted deliberately indifferent by discontinuing that treatment. The court stated:

[W]ith respect to the requested treatments in the forms of Oxycontin, Milk Thistle, and Vitamin C, the court finds plaintiff has met his burden for the issuance of a preliminary injunction. The evidence demonstrates that, in violation of Estelle [v. Gamble, 429 U.S. 97, 97 S.Ct. 285, 50 L.Ed.2d 251 (1976)], he was not allowed to continue with his prescribed treatment after transferring to his current facility, so there is a substantial likelihood of success on the merits of this claim. There is no dispute that plaintiff suffers from serious liver disease; the only question concerns the proper treatment. Plaintiff has been examined by Dr. Marlene Bynum and Dr. Barseloux at Griffin Memorial Hospital, and both recommended Oxycontin, Milk Thistle, and Vitamin C. Dr. Yarborough, the pain specialist, as would be expected, only made recommendations for plaintiffs pain management. Dr. Trout[ ] and Dr. Ryan apparently disagree with the private physicians, but they have failed to articulate the medical rationale for their denial of these treatments which were allowed at a previous DOC facility.

ApltApp. at 130. The district court then made specific findings concerning the remaining requirements for a preliminary injunction, stating that plaintiff will suffer irreparable harm if he is not allowed to continue the prescribed treatments and that the injunction will not cause damage to defendants or be adverse to the public interest. The court concluded “[t]his temporary injunction is effective immediately *814 and shall remain in force until further order of the court.” Id. at 131.

Defendants did not appeal the court’s September 21, 2001 order. Instead, on October 19, 2001, defendants filed their motion to terminate the injunction pursuant to the PLRA. In that motion, defendants argued that the district court failed to make the additional findings mandated by the PLRA and codified at 18 U.S.C. § 3626, that the injunction is narrowly drawn, extends no further than necessary, and is the least intrusive means necessary to correct the violation of the federal right. 18 U.S.C. § 3626(a)(1). Defendants also argued that, because the record presented only a difference of opinion between Alloway’s doctors, “there has been no finding that any of Plaintiffs Federal rights were violated.” ApltApp. at 132.

At a hearing on May 23, 2002, defendants added that the district court’s failure to make the required findings under § 3626(a)(1), and its failure to make the order “final” pursuant to § 3626(a)(2), resulted in the automatic termination of the injunction after ninety days. Defendants argued that the statement in the court’s order that the injunction “shall remain in force until further order of the court” contradicted § 3626(a)(2)’s automatic expiration provision, but that, even if the court were to make the required findings after-the-fact, defendants would present evidence demonstrating that those findings could not be made. There was some confusion over the scope of the hearing, as Alloway’s counsel objected to the presentation of medical evidence going to the issue of deliberate indifference, an issue which had been previously briefed and litigated. The magistrate judge ruled that defendants could present their evidence but limited it to issues arising after the preliminary injunction was granted on September 21, 2001. The magistrate judge stated:

[T]he appropriate issue is whether or not the defendant or the plaintiffs condition has changed since the last hearing. I think I will allow you to call your witness to testify with regard to whether or not the — the administration of these drugs poses a danger to him at the present point because of a change in his condition. I’m not going to allow a revisiting about whether or not this was the right medical treatment to be ordered in the injunction of September of 2001.

Aplt.App. at 146-47. The magistrate judge further ruled that defendants could present evidence showing the risk or harm to the prison system by providing Alloway’s treatment.

In her findings and recommendation dated May 30, 2002, the magistrate judge recommended denying defendants’ motion to terminate the injunction. As to defendants’ claim that there had been no finding that any of Alloway’s federal rights were violated, the magistrate judge reviewed the relevant evidence, including defendants’ evidence going to any adverse impact of Alloway’s treatment on the operation of the prison, and stated:

[T]he court’s order granting the injunction expressly made a finding that the defendants were deliberately indifferent to plaintiffs serious medical needs. The issue is not simply a difference of opinion; instead, it concerns whether plaintiffs established treatment could be summarily halted without medical justification. Throughout this litigation, the defendants have failed to offer a medical rationale for discontinuing plaintiffs treatments, but there has been ample evidence that the recommended treatments were appropriate and helpful.

Id.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
72 F. App'x 812, Counsel Stack Legal Research, https://law.counselstack.com/opinion/alloway-v-hodge-ca10-2003.